uploads///

Key Points of the July FOMC Meeting

By

Aug. 18 2017, Updated 2:46 p.m. ET

Rates left unchanged in July meeting

At the last FOMC (Federal Open Market Committee) meeting on July 26, 2017, interest rates remained unchanged. The FOMC released the minutes of that meeting about three weeks later on August 16, 2017. Those minutes include economic discussions and provide investors with insights into the reasons the Fed kept interest rates unchanged. There were discussions about the current size of the Fed’s balance sheet and plans to slowly reduce it. Several members were in favor of announcing a start date for the balance sheet reduction, but the decision was deferred to the next meeting since some members wanted to wait for additional data on economic expansion.

Article continues below advertisement

Key points discussed in the July meeting

At the July meeting, FOMC members discussed possible reasons for inflation (TIP) remaining below the Fed’s target, despite unemployment reaching record lows. There were interesting insights about members’ views on reducing the responsiveness of inflation (VTIP) to an increase in demand, a shift in the natural rate of unemployment to a lower level, and a lag in wage growth and inflation to a tightening labor market. There were also anecdotes about recent global developments and innovations in the field of technology, which are changing existing business models.

Series overview

In the remaining parts of this series, we’ll look at the Fed’s plan for shrinking its balance sheet. We’ll also look at its view on equity (VTI) valuations and how the current economic outlook could impact fixed income (BND) and the currency markets (UUP).

Advertisement

More From Market Realist

  • COVID-19 vaccine and Vaxart logo
    Healthcare
    Hate Injections? Vaxart Stock Might Be Attractive After the Crash
  • COVID-19 virus and Cocrystal Pharma logo
    Healthcare
    Cocrystal Pharma Stock Is a Speculative Play on COVID-19 Drug
  • Stethoscope and a smartphone
    Healthcare
    Why Bionovate Technologies (BIIO) Stock Is a Risky Bet in 2021
  • Precipio Biotech
    Healthcare
    Is Precipio (PRPO) a Good Stock to Buy? A Look at the Year Ahead
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.